Search dm+d | This VMP cannot be matched against our prescribing data.
Name | Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials |
BNF code | 1404000ATAAAEAE |
Virtual Therapeutic Moiety | COVID-19 vaccine |
Basis of preferred name | Other |
Date of name applicability | 16 Mar 2021 |
Previous name | Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials |
Basis of previous name | Other |
Reason for name change | Other |
Prescribing status | Never Valid To Prescribe As A VMP |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Non-availability | Actual Products not Available |
Non-availability status date | 27 Aug 2024 |
Dose form | Discrete |
Unit dose form size | 0.500 |
Unit dose form units | ml |
Unit dose unit of measure | dose |
Ontology Drug Form & Route | |
---|---|
Form & Route | suspensioninjection.intramuscular |
Dose Form | |
Formulation | Suspension for injection |
Drug Route | |
Route | Intramuscular |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Virtual Medicinal Product Packs | |
Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials 100 dose | |
Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials 10 dose |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.